| abstract |
A method for diagnosing, screening and/or monitoring the development of a proliferative disease like cancer by quantifying the amount and analyzing the methylation status of DNA in blood, serum, urine, saliva or other samples derived from an individual, comprising the following steps:n a) retrieving a bodily fluid sample from said individual; b) detecting the amount of total free floating DNA in said sample; c) determining the amount of free floating DNA that originates from said tissue or organ; d) determining the presence or absence of a medical condition based on the total amount of free floating DNA and the fraction of free floating DNA that originates from said tissue or organ. |